iiinova — where your digital self keeps evolving

VectorBuilder @vectorbuilder.bsky.social · 06/05/2026

This May, the VectorBuilder team is heading to key conferences across the globe! 🌍 Come meet our team and learn how our research and CDMO solutions are helping accelerate breakthroughs.

000

Reposted by VectorBuilder

Institute for Human Genetics at UCSF @ihgatucsf.bsky.social · 30/04/2026

Take a break and have lunch with @vectorbuilder.bsky.social :) humangenetics.ucsf.edu/lunch-and-le...

011

VectorBuilder @vectorbuilder.bsky.social · 04/05/2026

Tired of the clone wars? VectorBuilder’s got your back. Check out our Vector Design Studio and use our stable cell line engineering service to find the cells you’re looking for. Happy Star Wars Day, and may the force be with you!

000

VectorBuilder @vectorbuilder.bsky.social · 01/05/2026

It's the final day of CDMO Week 🧬 The conversation doesn’t stop here, this is just the beginning for what’s next in gene delivery!

000

VectorBuilder @vectorbuilder.bsky.social · 30/04/2026

Day 4 of #CDMOWeek 🧬 Juggling vector design, optimization & manufacturing? 😵‍💫 VectorBuilder helps you do it all, end to end 🚀 From vector design to GMP, all in one place (no chaos). Talk to the CliniVec™ team today for a free consultation!

000

VectorBuilder @vectorbuilder.bsky.social · 29/04/2026

For day three of our #CDMOWeek, we’re sharing a recent article from the @nytimes.com highlighting how our customers at Neion Bio are rethinking biologics manufacturing, developing chicken-based systems that aims to use eggs as platforms for drug production. www.nytimes.com/2026/03/26/s...

nytimes.com

How to Turn a Chicken Egg Into a Drug Factory

100

VectorBuilder @vectorbuilder.bsky.social · 28/04/2026

It's Day 2 of #CDMOWeek! Meet the VectorBuilder team at #ISCT2026 in Dublin, Ireland! Be sure to stop by Booth 1905 to learn how VectorBuilder is supporting cell and gene therapy development and translational research from our latest array of products and services.

000

VectorBuilder @vectorbuilder.bsky.social · 27/04/2026

It’s day 1 of #CDMOWeek 🧬 VectorBuilder is a full-service CDMO supporting every stage of gene therapy—from vector design to GMP manufacturing and QC. Hear from our Head of CDMO Operations, Dr. Alan Griffith, on how we can support your pipeline 👇

000

VectorBuilder @vectorbuilder.bsky.social · 20/04/2026

☀️VectorBuddy and the VectorBuilder team are in sunny San Diego for @theaacr.bsky.social annual conference, #AACR2026! We are excited to discuss our newest offerings and services to support your cancer research, so be sure to check out Booth 4153.

000

VectorBuilder @vectorbuilder.bsky.social · 17/04/2026

Are you ready to kick-off #IMMUNOLOGY2026 ? The VectorBuilder team is excited to join the American Association of Immunologists (aai.org) at their annual IMMUNOLOGY conference in Boston. 🗓️ April 15-19, 2026 📍Booth 427 - Thomas M. Menio Convention & Exhibition Center Hall A

010

VectorBuilder @vectorbuilder.bsky.social · 14/04/2026

Our new preprint introduces MuteFree™ AAV, a high-stability vector system designed to address ITR instability, a common challenge in gene therapy development. The manuscript is now available on bioRxiv. www.biorxiv.org/content/10.6...

110

VectorBuilder @vectorbuilder.bsky.social · 13/04/2026

VectorBuilder is pleased to exhibit at British Society for Gene and Cell Therapy’s Annual Conference 2026 (bsgct.bsky.social). Have a chat with Christina McClure and Tasnim Hussain to learn about our latest offerings and services for your research and therapeutic development projects.

000

VectorBuilder @vectorbuilder.bsky.social · 13/04/2026

Alzheimer’s disease develops before symptoms appear, but early brain changes are not fully understood. New work from the Misha Zilberter lab shows APOE4 drives neuronal hyperexcitability in mice and identifies Nell2 as a mediator. CRISPRi KD of Nell2 normalized activity, pointing to an early target.

030

VectorBuilder @vectorbuilder.bsky.social · 10/04/2026

For the scientists who know good science and good style go hand in hand 🧬 Coming soon… and yes, you’ll definitely want some.

000

VectorBuilder @vectorbuilder.bsky.social · 09/04/2026

To celebrate 12 years of VectorBuilder, we’re making it easier to get your next few projects off the ground! We’ve set up a ""Savings Roadmap"" that scales with your research: 1st Order: 20% OFF (Code: Thankyou1st) 2nd Order: 15% OFF 3rd Order: 10% OFF

100

VectorBuilder @vectorbuilder.bsky.social · 03/04/2026

Trying to figure out if mosaic screening is right for your cancer research? Dr. James Allen, HHMI Hanna Gray Fellow & incoming faculty at Mayo Clinic, highlights mosaic screening approaches in zebrafish and its applications to discovering genetic interactions that contribute to pediatric leukemia.

100

VectorBuilder @vectorbuilder.bsky.social · 02/04/2026

mRNA is moving beyond vaccines, but where is it going next? Join our next Gene Delivery Seminar to learn how advances in mRNA design are enabling precise, transient protein expression across diverse disease areas.

110

VectorBuilder @vectorbuilder.bsky.social · 01/04/2026

99% of grad students agree: cloning is their favorite technique. The other 1% are still troubleshooting. …okay fine, we made that up. Happy April Fools’ Day! Leave the cloning to us 🧬

010

VectorBuilder @vectorbuilder.bsky.social · 31/03/2026

This April, the VectorBuilder team is heading to key conferences across the globe! 🌍 Come meet our team and learn how our research and CDMO solutions are helping accelerate breakthroughs.

010

VectorBuilder @vectorbuilder.bsky.social · 31/03/2026

HIV requires lifelong treatment to maintain viral control, driving interest in approaches that enable sustained anti-HIV antibody production. New work from Jack Castelli, PhD and the Adair lab shows CRISPR knock-in in primate HSPCs enables long-term antibody production in vivo.

010

VectorBuilder @vectorbuilder.bsky.social · 27/03/2026

Still paying for molecular biology software? VectorBee is the forever-free platform for vector design, editing, annotation, and analysis. No more paywalls, because your research deserves better! Try VectorBee today: hubs.la/Q048fYHx0

000

VectorBuilder @vectorbuilder.bsky.social · 26/03/2026

Happening today! 🧬 Join today’s Gene Delivery Seminar to learn how you can optimize your lentiviral vectors for reliable gene delivery!

010

VectorBuilder @vectorbuilder.bsky.social · 25/03/2026

People are buzzin’ about VectorBee! 🐝 Researchers like Dr. Zubair Khalid @zubairkhalidphd.bsky.social are exploring how VectorBee can support their workflows in the lab. Our goal is to make research tools more accessible, without subscriptions, locked features, or limitations.

110

VectorBuilder @vectorbuilder.bsky.social · 23/03/2026

Going to #CDU2026? Our team will be excited to chat at CRISPR Down Under in Melbourne next week. 🧬 Stop and chat with Dr. Chee Ho H'ng (Territory Manager) to learn more about the new CRISPR and research solutions we can support for your research. See you there!

010

VectorBuilder @vectorbuilder.bsky.social · 18/03/2026

🐝 What should every student learn about vector design? In this last video, Dr. Shirley Coomber explains how VectorBee helps students understand the core elements of plasmid design, from selecting promoters to building functional expression vectors.

100

VectorBuilder @vectorbuilder.bsky.social · 17/03/2026

🐝 We recently visited Dr. Shirley Coomber’s Molecular Biology Research Skills workshop at King's College London to see how students are learning vector design with VectorBee.

100

VectorBuilder @vectorbuilder.bsky.social · 16/03/2026

🐝 Did you know VectorBee is helping train the next generation of scientists? In this first video, Dr. Shirley Coomber shares how she uses VectorBee to teach plasmid design in her Molecular Biology Research Skills course @kingscollegelondon.bsky.social

100

VectorBuilder @vectorbuilder.bsky.social · 13/03/2026

Fine-tune your coding sequences with VectorBee 3.0. Choose CDS translation, select reading frames, display labels on vector and sequence maps, and preview predicted protein size. 🐝 Try VectorBee, forever free: www.vectorbee.com/en/

000

VectorBuilder @vectorbuilder.bsky.social · 12/03/2026

Why does lentivirus remain one of the most widely used gene delivery platforms? 🧬 In our upcoming Gene Delivery Seminar, you’ll learn about the features that make lentiviral vectors so effective and how you can optimize them for your research. Register here: us06web.zoom.us/webinar/regi...

us06web.zoom.us

000

VectorBuilder @vectorbuilder.bsky.social · 12/03/2026

Work with your enzymes, your way. Quickly identify restriction sites for selected enzymes using the new Enzyme List Visualization feature and run more interactive gel simulations in VectorBee 3.0 🐝 Try VectorBee, forever free: www.vectorbee.com/en/

010

VectorBuilder @vectorbuilder.bsky.social · 11/03/2026

Experience the smoothest sequence alignments with VectorBee 3.0. You can now edit chromatogram samples directly within alignment projects, with improved visualization and chromatogram–sequence interaction. Plus expanded import options, alignment draft saving, and sample information editing.

100

VectorBuilder @vectorbuilder.bsky.social · 10/03/2026

Join us at the Midwest CRISPR Animal Modeling Symposium (M-CAMS 2026) for a training session on connecting genomic discovery with vector design.

100

VectorBuilder @vectorbuilder.bsky.social · 10/03/2026

Designing, editing, annotating, and analyzing vectors shouldn’t feel like juggling. VectorBee 3.0’s refreshed interface makes switching between project panels easier than ever - clean, simple, and intuitive. 🐝 Try VectorBee, forever free: www.vectorbee.com/en/

010

VectorBuilder @vectorbuilder.bsky.social · 09/03/2026

Work your magic with VectorBee 3.0 — meet the Vector Design Wizard. 🐝 Vector design just got easier. With only a few clicks, the Vector Design Wizard lets you create vectors, annotate sequences, run analyses, and place your order all in one place!

100

VectorBuilder @vectorbuilder.bsky.social · 09/03/2026

Are AAVs dead - or do LNPs still have a way to go? If you’re at the Royal College of Surgeons ( @rcsi.bsky.social ) in Ireland this Wednesday, join Dr. Alan Griffith as he breaks down the strengths and limitations of AAV and LNP gene delivery platforms.

000

VectorBuilder @vectorbuilder.bsky.social · 06/03/2026

Going to ELRIG's Cell and Gene Therapy Conference? 🧬 Our team will be excited to connect at Cell & Gene Therapy 2026 in Cambridge. Stop by our Booth #9 and chat to one of our team members to learn about our latest offerings and solutions for your CGT research. See you there!

000

VectorBuilder @vectorbuilder.bsky.social · 06/03/2026

🆕 We’re excited to introduce VectorBee 3.0, with over 17 new and optimized features for vector design and molecular biology analysis. And the best part: it’s still forever free! These improvements will streamline your workflows, giving you more time to focus on the research that matters.

100

VectorBuilder @vectorbuilder.bsky.social · 05/03/2026

🧬 What makes lentivirus such a powerful gene delivery tool? Join our next Gene Delivery Seminar to learn how you can optimize lentiviral vectors for stronger performance in your research and clinical applications.

100

VectorBuilder @vectorbuilder.bsky.social · 04/03/2026

Excited to highlight recent work from the Romain Loyon lab exploring TCR-based strategies to target the oncogene SALL4 in solid tumors. Engineered T cells reduced tumor growth in preclinical models, supporting further development of precision T cell therapies for cancer.

100

VectorBuilder @vectorbuilder.bsky.social · 03/03/2026

Looking to streamline your RNAi workflow? Our shRNA platform supports intuitive design, flexible delivery, and stable knockdown: silence genes and amplify your results. Sequence-guaranteed, fast turnaround, and dedicated technical support.

100

VectorBuilder @vectorbuilder.bsky.social · 02/03/2026

March is Colorectal Cancer, Kidney Cancer, Multiple Myeloma, and Endometriosis Awareness Month. Behind every diagnosis is a patient who deserves better treatments and outcomes. At VectorBuilder, we support scientists advancing earlier detection and novel therapies so breakthroughs reach patients.

000

VectorBuilder @vectorbuilder.bsky.social · 27/02/2026

On #RareDiseaseDay, we recognize the 300+ million people worldwide living with a rare disease. Most of these conditions still lack approved treatments, leaving patients with limited options. At VectorBuilder, we support researchers advancing new therapies and stand with the rare disease community.

020

VectorBuilder @vectorbuilder.bsky.social · 26/02/2026

Marching into the next month of 2026 ☘️ Don't miss the VectorBuilder team at the next key conferences! Excited to see you there!

000

VectorBuilder @vectorbuilder.bsky.social · 25/02/2026

Interested in using tissue-clearing techniques to study intact samples in 3D? Check out our seminar with Dr. @cristina-mtz-glz.bsky.social as she introduces novel tissue-clearing strategies and key considerations for selecting the right protocol for different samples and research objectives.

111

VectorBuilder @vectorbuilder.bsky.social · 24/02/2026

Have you heard of LentiBuilder™? Level up your lentivirus production. ✅ Ultra-high titers, even with oversized genomes ✅ Powerful transduction, even in complex cells ✅ Minimal steps, maximum expression See what our customers are saying.

000

VectorBuilder @vectorbuilder.bsky.social · 19/02/2026

🧬 Happening today! Join our Gene Delivery Seminar to learn how disease models are used to study early genetic events in vivo and what they reveal about how disease begins. Register now!

000

VectorBuilder @vectorbuilder.bsky.social · 18/02/2026

Excited to highlight new work from the @roychoudhurilab.bsky.social showing control of BACH2 dosage can improve adoptive T cell therapies. Low-dose BACH2 promotes T cell persistence without compromising effector function, enhancing antitumor activity. A step forward for personalized immunotherapy.

000